Objective: The fate of transplanted cells used in tissue engineering strategies should be followed. With this aim in view, the survival of transplanted bone-marrow-derived mesenchymal cells within osteochondral defects was determined using transgenic rats to simulate autologous transplantation.
Introduction
Although osteochondral defects repair spontaneously, the tissue formed is of variable quality, ranging from a fibrous through a fibrocartilaginous type to one of a hyaline-like cartilaginous nature, depending on species and age as well as on the location and the size of the defect 1e3 . However the original hyaline cartilage is not regenerated. The tissue degenerates gradually with time and osteoarthritis usually ensues 4e6 . In order to facilitate the repair of defects, tissues of various type, such as periosteal, perichondrial, or osteochondral, have been transplanted 7e10 . Various cell types also such as chondrocytes or mesenchymal cells, have been applied, with resulting improvements in the hyalinelike quality of the repair cartilage formed and in the clinical symptoms 11e18 . However, true regeneration of the original hyaline cartilage layer still has not been achieved either biochemically or biomechanically, and the ideal source of cells for defect healing remains elusive. In many trials, autologous transplantation has been undertaken in that it avoids the problem of immunological rejection by the host against the transplanted cells 11, 12, 19 . However, it is difficult to distinguish the autologously transplanted cells from host cells. Hence, it is still debated whether the transplanted cells do actually survive and, if so, whether they do indeed contribute to the formation of the repair tissues. It is thus essential to follow the fate of the autologously transplanted cells during the repair process and to ascertain whether they themselves repopulate the defect or whether they merely stimulate the host cells resident within the surrounding tissues to enter it 12 . Bone-marrow tissue contains mesenchymal stem cells which are known to contribute to the regeneration of mesenchymal tissues by differentiating into mesenchymallineage progenitor cells, such as osteoblasts, chondroblasts, fibroblasts, myoblasts or lipoblasts 20, 21 . It has been hypothesized that autologously transplanted mesenchymal cells survive at the transplantation site and contribute to the repair of osteochondral defects by forming both cartilage and subchondral bone tissue.
In our previous publication, we reported on a simulated autologous transplantation model involving transgenic rats which could be used to monitor the fate of the autologously transplanted cells. In this model, inbred female transgenic rats serve as the cell donors and their wild-type counterparts as the recipients, transplantation being effected without immunological rejection. Since the transgenes are present homozygously within the transplanted cells, DNA probes hybridize to both the relevant chromosomes using the in situ hybridization technique. Hence, this model permits a distinction between transplanted and host cells in vivo, provided that the former survive 22, 23 . The objective of the present study was to follow the fate of transplanted bone-marrow-derived mesenchymal cells during the repair of osteochondral defects using this transgenic rat model.
Materials and methods

ANIMALS
Big Blue transgenic (Stratagene, La Jolla, CA) and Fischer 344 wild-type female rats, aged 12 weeks and weighing 200e250 g, were used in this study.
The Big Blue transgenic rat lineage is generated from the Fischer 344 wild-type. Each of the cells of this transgenic rat type contains 50e70 copies of a bacteriophage lambda shuttle vector, which is homozygous for the bacterial promoters lacI, alacZ, and Amp r . The lacI target gene encodes the lac repressor protein, which binds to the lac operator and blocks the transcription of the lacZ promoter gene. Since the transcription of transgenes is theoretically suppressed in mammals, they produce no foreign proteins from these. Hence, transplantation between the transgenic and the wild-type rat can be effected without immunological rejection, and the model is thus considered to simulate autologous transplantation 24, 25 . All experimental procedures employed in this study have been approved by the Committee for Animal Research at the Kyoto Prefectural University of Medicine, Japan.
CULTURING OF MESENCHYMAL CELLS
Transgenic female rats (n Z 4) were anesthetized by an intraperitoneal injection of sodium pentobarbital (35 mg/kg of body weight) and then killed. Bone-marrow cells were removed bilaterally from the femora and tibiae under sterile conditions and then suspended in phosphate-buffered saline (PBS) containing 2% bovine serum albumin [(BSA) Serologicals Proteins Inc., Kankakee, IL]. The cell suspensions were then centrifuged (200 ! g for 5 min) to remove serum components. The sedimented cells were treated with sterile water for 10 s to disrupt the erythrocytes. They were then resuspended in PBS containing 2% BSA and again centrifuged (200 ! g for 5 min). The number of bonemarrow cells was determined using a hemocytometer. Each rat yielded approximately 3 ! 10 6 to 5 ! 10 6 cells, including non-adhering ones and erythrocyte cells. The cells were transferred to 100-mm-diameter culture dishes (FALCON, Franklin Lakes, NJ) to which Dulbecco's modified Eagle medium [(DMEM) GIBCO, Grand Island, NY] containing 10% fetal bovine serum [(FBS) ICN Biomedicals Inc., Aurora, OH] and 0.06% kanamycin was added. The cultures were incubated at 37(C in a humidified atmosphere containing 5% CO 2 . The medium was first changed 24 h after seeding and then every 3 days during the 10e14 days of culturing in order to remove non-adhering cells. At the end of the culture period, the growing fibroblast-like cells, which were considered to be of mesenchymal origin, were 80% confluent. The cells were detached from the culture dishes by treatment with 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) for 5 min. They were then counted in a hemocytometer.
GENERATION OF DENSE CELL MASSES
The mesenchymal cells were transferred to DMEM containing 10% FBS and 0.06% kanamycin and maintained in hanging-drop culture in a humidified atmosphere containing 5% CO 2 at 37(C for 60e72 h. Drops of cell suspension were hung from the inside surface of the culture dish covers. The cells gradually settled at the bottom of the drop where they aggregated to form dense masses. Each 40-ml drop initially contained 4 ! 10 3 cells. Approximately 24e28 cell masses, each about 0.6 mm in diameter, were obtained from a single rat.
PREPARATION AND TREATMENT OF THE OSTEOCHONDRAL DEFECTS IN WILD-TYPE RATS
Wild-type female rats (n Z 32) were anesthetized by an intraperitoneal injection of sodium pentobarbital. An anterior midline incision was made through the skin of the right knee and the articular surface of the femur was then exposed using a medial parapatellar retinacular approach. The knee joint was immobilized in a deeply flexed position, and a cylindrical osteochondral defect, 1.5 mm in diameter and 3 mm in depth, was then created in the central weightbearing surface of the medial femoral condyle using a 22-gauge needle. In the experimental group (n Z 16), four separate masses of mesenchymal cells were introduced into the defects and affixed therein with fibrin glue (Beriplast, Aventis, Bridgewater, NJ). In the control group (n Z 16), the defects were filled with fibrin glue alone. All rats were permitted free cage movement after surgery.
MACROSCOPIC AND HISTOLOGICAL EVALUATION
Four, 8, 12 and 24 weeks after surgery, the wild-type rats were anesthetized with sodium pentobarbital, and then perfused with physiological saline followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB). The distal portions of the femora were removed and immersed in the same fixative solution (4% PFA in 0.1 M PB) for 24 h at 4(C. They were then decalcified in 0.5 M EDTA ( pH 7.5) for 2 weeks at ambient temperature, this procedure being followed by gradient replacement with 20% sucrose for 24 h at 4(C. The femora were then rapidly frozen and cryosectioned in a cryostat (CM3050 S, Leica, Nussloch, Germany). The 14-mm-thick sections were stained either with 0.01% safranin O or with 0.05% toluidine blue in preparation for light microscopy. The following features were assessed: surface regularity, thickness of the cartilage layer, repair of the subchondral bone layer, matrix-staining of the cartilaginous and bony compartments, and integration of the repair tissue with the surrounding host tissues. The extent of the inflammatory response and osteophyte formation were also evaluated.
IN SITU HYBRIDIZATION
Transgenes within the transplanted cells were detected at the 24-week juncture by in situ hybridization, which was 812 Y. Oshima et al.: Fate of Mesenchymal Cells in Osteochondral Defects performed as previously described 22, 23 . Briefly, the DNA probe was prepared by Nick translation using digoxigenin-11-dUTP (Roche, Mannheim, Germany). The transgene of a Big Blue transgenic rat (Lambda shuttle vector, Stratagene) served as a template. Cryosections were fixed in 4% PFA for 15 min at ambient temperature, digested with 0.8% pepsin in 0.2 M HCl for 15 min at 37(C and then again fixed in PFA for 15 min, after which they were dehydrated in ethanol at ambient temperature. Chromosomal DNA was denatured by treating the sections first with 70% formamide in double-strength sodium saline citrate for 5 min at 70(C, then with ice-cold 70% ethanol for 5 min and finally with 100% ethanol for a similar period. The denatured DNA probe was transferred to the sections and the hybridization then carried out overnight at 37(C. The sections were incubated with alkaline-phosphatase-conjugated anti-digoxigenin antibody Fab-fragments (Roche, Mannheim, Germany) for 30 min, and the reaction product was then visualized by treatment with 4-nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt for 8e12 h. The sections were then evaluated microscopically.
Results
MACROSCOPIC OBSERVATIONS
In neither the experimental nor the control group of rats were signs of infection, immunological rejection, osteophyte formation or osteoarthritis apparent in the knees at any time after surgery (4, 8, 12 or 24 weeks). In the control group (fibrin glue alone), the defect margins were clearly recognizable at 4, 8, 12 and 24 weeks. At 4 weeks, the defect surfaces were slightly depressed and covered with a shiny, semi-transparent tissue. After 24 weeks, the defect surfaces were still slightly depressed and more irregular than at 4 weeks [ Fig. 1(AeD) ]. In the experimental group (transplanted mesenchymal cells and fibrin glue), the margins of the defects were likewise recognizable 4 weeks after surgery. Similarly, their surfaces were slightly depressed and covered with a shiny, semi-transparent tissue. At 8 and 12 weeks, the margins of the defects were still recognizable but their surfaces, though irregular, were not depressed. At 24 weeks, the margins of the defects were still discernible but not sharply defined. Their surfaces were smooth and evinced no obvious signs of degeneration [ Fig. 2(AeD) ].
HISTOLOGICAL OBSERVATIONS
In the control group, the margins of the defects were clearly recognizable and their surfaces were slightly irregular 4 weeks after surgery. They were filled with fibrous tissue, which failed to stain with either safranin O or toluidine blue. No osseous tissue was observed within the bony portion of the defects [ Fig. 3(A) ]. Likewise at 8 and 12 weeks, the margins of the defects were clearly recognizable and their surfaces were slightly irregular. They were still filled with fibrous tissue. Neither cartilage nor bone was observed within the respective compartments [ Fig. 3(B, C) ]. At 24 weeks, isolated patches of cartilage tissue, which were stained faintly with safranin O, were apparent, but most of the defect area was still filled with fibrous tissue [ Fig. 3(D) ].
In the experimental group, the margins of the defects were clearly recognizable 4 weeks after surgery and their surfaces were slightly irregular. They were filled with fibrous tissue, which was well integrated with the surrounding bone in the deeper regions. The tissue stained intensely with safranin O and metachromatically with toluidine blue, indicating the presence of a cartilaginous matrix. Numerous cells within the repair tissue were surrounded by a lacuna and they were thus deduced to be chondrocytes. However, they were isotropically organized. The repair cartilage was thicker than the normal cartilage layer [ Fig. 4(A) ].
At 8 weeks, the margins of the defects were still recognizable and their surfaces were slightly irregular. The repair cartilage was still thicker than the normal cartilage layer. The bony compartment contained mostly fibrous tissue, although some new bone had been laid down in the deeper regions [ Fig. 4(B) ].
At 12 weeks, the margins of the defects were still recognizable and their surfaces were less irregular than at 8 weeks [ Fig. 4(C) ]. By 24 weeks, the defect surfaces were smooth and no longer depressed. At both 12 and 24 weeks, the matrix of the repair cartilage stained positively with safranin O staining, but, as at 8 weeks, the chondrocytes were isotropically arranged. By 24 weeks, the thickness of the repair cartilage had decreased slightly but the height of the normal cartilage layer had not been attained. In deeper regions of the bony compartment, the osseous tissue was well remodeled and well integrated with host bone [Fig. 4(D) ].
IN SITU HYBRIDIZATION
For the in situ hybridization, sections of wild-type rat femora served as negative controls and those of transgenic ones as positive controls. Since all cells of the transgenic rats are homozygous for the transgenes, the DNA probes Positive cells were detected within the cartilage, subchondral bone, and bone marrow of transgenic rats (positive control), but not within the corresponding tissues of the wild-type ones [(negative control) Fig. 5(AeD) ]. In the experimental group of rats, positive cells were observed within both the cartilaginous [ Fig. 5(E) ] and the bony [ Fig. 5(F) ] compartments of the defects 24 weeks after transplantation. This finding indicates that the repair tissues contained cells that were derived from the transplanted ones. To assess the proportion of positive cells in each type of repair tissue, the numbers were counted in randomly selected areas (0.14 mm ! 0.21 mm) at a magnification of !160 in the light microscope. Approximately 30e40% of cells in the cartilaginous layer and about 10e20% of those in the subchondral bone layer, at a maximum, registered positive.
Discussion
In this study, mesenchymal cells derived from the bone marrow of transgenic rats were transplanted into osteochondral defects created in their wild-type counterparts. Twenty-four weeks after surgery, the cartilaginous compartment of the defects was filled with a hyaline-like type of repair cartilage and the bony portion with osseous tissue. Each layer contained cells that were derived from the transplanted mesenchymal population.
Several tools, such as radioisotopes, gene markers and cell-surface antigens, have hitherto been employed to follow the fate of autologously transplanted cells. However, their use may be associated with one of several disadvantages, such as a temporal reduction in signal intensity, immunological rejection or selective marking 26e30 . The transgenic rat method used in the present study circumvents these difficulties.
The mesenchymal cell masses used for transplantation were prepared by the hanging-drop culture technique, which was originally developed for the three-dimensional culturing of thymus cells 31 . By this means, cell agglomerations of high density can be obtained. The concentration process does not have an obviously adverse influence on the mesenchymal cells, since more than 90% of the population survived it according to the trypan-blue exclusion test.
Fibrin glue was used to affix the cell masses within the defects. The material acts instantaneously, thereby preventing cell loss 32, 33 , and elicits no immunological response. Fibrin glue alone (control group) was not capable of inducing compartment-specific repair of the osteochondral defects.
The potential of bone-marrow-derived mesenchymal cells to form cartilage and bone is well known 14, 20, 21, 34, 35 . An additional advantage of using bone-marrow cells in a clinical context is that they are obtainable by minimally invasive means.
Using our simulated autologous transplantation model in conjunction with in situ hybridization, we ascertained that the transplanted mesenchymal cells contributed to the cell populations in the repair tissues, albeit to different degrees: 30e40% in the cartilaginous compartment and 10e20% in the bony one, at a maximum. Hence, transplanted mesenchymal cells are capable of facilitating the compartmentspecific repair of osteochondral defects. However, the repair result achieved is not ideal. Further studies, involving perhaps growth factors and gene therapy, must now be undertaken to optimize regeneration of the original hyaline cartilage layer 36, 37 . Notwithstanding, our finding that transplanted mesenchymal cells contribute a part of the repair tissues is an important one. This information may help us to fathom the role played by these cells in the healing of osteochondral defects.
